Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123486
Filing Date
2024-11-07
Accepted
2024-11-07 16:58:46
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-20240930.htm   iXBRL 10-Q 1725977
2 EX-31.1 crbp-ex31_1.htm EX-31.1 16414
3 EX-31.2 crbp-ex31_2.htm EX-31.2 16522
4 EX-32.1 crbp-ex32_1.htm EX-32.1 9231
5 EX-32.2 crbp-ex32_2.htm EX-32.2 9179
  Complete submission text file 0000950170-24-123486.txt   8166031

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240930.xsd EX-101.SCH 1333579
78 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240930_htm.xml XML 1343757
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 241436859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)